Active mouse MAPK10 full length protein (ab119734)

Overview

Description

  • NatureRecombinant
  • SourceBaculovirus infected sf9 cells
  • Amino Acid Sequence
    • AccessionQ61831
    • SpeciesMouse
    • Molecular weight71 kDa including tags
    • Amino acids1 to 464

Specifications

Our Abpromise guarantee covers the use of ab119734 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Biological activitySpecific Activity: 35 nmol/min/mg
  • Applications

    Western blot

    Functional Studies

    SDS-PAGE

  • Purity> 80 % by SDS-PAGE.
    Purity determined to be >80% by densitometry.
  • FormLiquid
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.

    pH: 7.50
    Constituents: 0.79% Tris HCl, 25% Glycerol, 0.004% DTT, 0.003% EDTA, 0.31% Glutathione, 0.002% PMSF, 0.88% Sodium chloride

    This product is an active protein and may elicit a biological response in vivo, handle with caution.

General info

  • Alternative names
    • c Jun kinase 3
    • c-Jun N-terminal kinase 3
    • cJun N terminal kinase 3
    • FLJ12099
    • FLJ33785
    • JNK3
    • JNK3 alpha protein kinase
    • JNK3A
    • MAP kinase
    • MAP kinase 10
    • MAP kinase p49 3F12
    • MAPK 10
    • Mapk10
    • MGC50974
    • mitogen activated protein kinase 10
    • Mitogen-activated protein kinase 10
    • MK10_HUMAN
    • p493F12
    • p54bSAPK
    • PRKM10
    • protein kinase mitogen activated 10
    • SAPK1b
    • Stress activated protein kinase 1b
    • stress activated protein kinase beta
    • Stress activated protein kinase JNK3
    • Stress-activated protein kinase JNK3
    see all
  • FunctionResponds to activation by environmental stress and pro-inflammatory cytokines by phosphorylating a number of transcription factors, primarily components of AP-1 such as c-Jun and ATF2 and thus regulates AP-1 transcriptional activity. Required for stress-induced neuronal apoptosis and the pathogenesis of glutamate excitotoxicity.
  • Tissue specificitySpecific to a subset of neurons in the nervous system. Present in the hippocampus and areas, cerebellum, striatum, brain stem, and weakly in the spinal cord. Very weak expression in testis and kidney.
  • Involvement in diseaseDefects in MAPK10 are a cause of epileptic encephalopathy Lennox-Gastaut type (EELG) [MIM:606369]. Epileptic encephalopathies of the Lennox-Gastaut group are childhood epileptic disorders characterized by severe psychomotor delay and seizures. Note=A chromosomal aberration involving MAPK10 has been found in a single patient. Translocation t(Y;4)(q11.2;q21) which causes MAPK10 truncation.
  • Sequence similaritiesBelongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. MAP kinase subfamily.
    Contains 1 protein kinase domain.
  • DomainThe TXY motif contains the threonine and tyrosine residues whose phosphorylation activates the MAP kinases.
  • Post-translational
    modifications
    Dually phosphorylated on Thr-221 and Tyr-223, which activates the enzyme. Weakly autophosphorylated on threonine and tyrosine residues in vitro.
  • Cellular localizationCytoplasm.
  • Information by UniProt

Active mouse MAPK10 full length protein images

  • The specific activity of ab119734 was determined to be 35 nmol/min/mg.
  • SDS-PAGE analysis of ab119374.

References for Active mouse MAPK10 full length protein (ab119734)

ab119734 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab119734.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"